Neurogene Newsroom

H.C. Wainwright Maintains Neurogene(NGNE.US) With Buy Rating, Maintains Target Price $55

Moomoo NewsNov 25 07:40 ET

Neurogene Price Target Maintained With a $55.00/Share by HC Wainwright & Co.

Dow JonesNov 25 07:33 ET

Neurogene Analyst Ratings

BenzingaNov 25 07:23 ET

TD Cowen Maintains Neurogene(NGNE.US) With Buy Rating

Moomoo NewsNov 21 08:31 ET

Stifel Maintains Neurogene(NGNE.US) With Buy Rating, Maintains Target Price $46

Moomoo NewsNov 21 08:31 ET

Stifel Maintains Neurogene(NGNE.US) With Buy Rating, Raises Target Price to $46

Moomoo NewsNov 20 22:31 ET

TD Cowen Maintains Neurogene(NGNE.US) With Buy Rating

Moomoo NewsNov 20 19:31 ET

Neurogene's Resilient Clinical Progress and Strong Financial Position Support Buy Rating

TipRanksNov 20 19:20 ET

Neurogene Is Maintained at Outperform by BMO Capital

Dow JonesNov 20 09:17 ET

BMO Capital Maintains Neurogene(NGNE.US) With Buy Rating, Cuts Target Price to $60

Moomoo NewsNov 19 08:31 ET

A Quick Look at Today's Ratings for Neurogene(NGNE.US), With a Forecast Between $46 to $60

Moomoo NewsNov 19 08:01 ET

Neurogene Analyst Ratings

BenzingaNov 19 06:42 ET

Positive Interim Clinical Data and Strategic Developments Justify Buy Rating for Neurogene

TipRanksNov 13 02:11 ET

Positive Buy Rating for Taysha Gene Therapies Amidst Competitive Advantages Over Neurogene

TipRanksNov 13 02:07 ET

Neurogene (NGNE) Receives a Buy From Stifel Nicolaus

TipRanksNov 12 09:20 ET

Baird Maintains Neurogene(NGNE.US) With Buy Rating, Raises Target Price to $72

Moomoo NewsNov 12 07:34 ET

TD Cowen Maintains Neurogene(NGNE.US) With Buy Rating

Moomoo NewsNov 12 07:31 ET

Analysts Offer Insights on Healthcare Companies: AstraZeneca (AZN) and Neurogene (NGNE)

TipRanksNov 12 07:26 ET

Neurogene Is Maintained at Buy by HC Wainwright & Co.

Dow JonesNov 12 06:57 ET

Neurogene Analyst Ratings

BenzingaNov 12 06:47 ET